Raymond Perez
Global Project Immunomodulatory Agents Head Sanofi
Seminars
Tuesday 9th September 2025
From Bench to Bedside: Early Phase Clinical Insights Into SAR445710 (KD033) and SAR445877 (KD050), Distinct Cytokines Targeting PDL1 or PD1
2:15 pm
- Reviewing Phase I safety, pharmacokinetic, pharmacodynamic, and preliminary efficacy data
- Understanding the translational relevance of preclinical findings in clinical settings
- Looking to future directions for PD-1/PD-L1-targeting cytokines in immune-oncology pipelines
